-
Ligand Pharmaceuticals (NASDAQ:LGND) Receives "Buy" Rating from HC Wainwright
Source: Buzz FX / 08 Nov 2024 09:01:18 America/Chicago
Ligand Pharmaceuticals (NASDAQ:LGND) Receives "Buy" Rating from HC Wainwright Written by MarketBeat November 8, 2024 Share Link copied to clipboard. Ligand Pharmaceuticals ( NASDAQ:LGND - Get Free Report ) 's stock had its "buy" rating rest
Read more...